心血瘀阻证、痰阻心脉证和心阴亏虚证等证候为冠心病患者的主要证候特点。
The syndrome types are mostly heart blood stasis syndrome, heart collaterals obstruction due to phlegm accumulation syndrome and heart-Yin deficiency syndrome.
心功差者采用吸入1％以下异氟醚维持亦称安全，尤适用于伴有低排高阻者。
The results also suggest that giving less than 1% isoflurane might be quite (?) safe especially in those with low CO and high SVR.
给出了前阻、法向力及压心随马赫数或几何参数的变化曲线。
The paper gives variations in the forebody drag, the normal force and the pressure center in accordance with the Mach Numbers and the geometric parameters.
冠心病基本病机为心脉瘀阻，临床和实验研究表明血瘀证是CHD最常见的证型之一。血管内皮功能的失调可能是CHD血瘀证的一个特征。
The heart blood stasis syndrome is one of the commonest syndrome, the vessel endothelial dysfunction is probably one of characteristics of HBSS in CHD.
目的：评价心达康胶囊治疗冠心病心绞痛(胸痹心血瘀阻证)的临床疗效与安全性。
AIM: to evaluate the efficacy and safety of xindakang capsules in the treatment of patients with angina pectoris.
结论：心达康胶囊治疗冠心病心绞痛(胸痹心血瘀阻证)安全、有效。
CONCLUSION: Xindakang capsule is an effective and safe drug in treating angina pectoris.
结论：心达康胶囊治疗冠心病心绞痛(胸痹心血瘀阻证)安全、有效。
CONCLUSION: Xindakang capsule is an effective and safe drug in treating angina pectoris.
应用推荐